| HRQOL Questionnaire items |
HRQOL items scores[median (IQR)] |
| Mean CD4 count (/mm3) |
OIs during ART |
Cotrimoxazole prophylaxis |
| ≤ 350
(n=150) |
> 350
(n=81) |
p |
No
(n=73) |
Yes (n=158) |
p |
No
(n=23) |
Yes (n=208) |
p |
| Global HRQOL score |
80.83
(72.85-86.91) |
80.06
(73.98-86.76) |
0.97 |
80.52
(72.74-86.84) |
81.21
(75.6-87.36) |
0.45 |
77.79
(73.05-83.36) |
80.96
(72.95-87.23) |
0.22 |
| GHP |
60
(50-70) |
60
(50-70) |
0.68 |
60
(50-70) |
65
(55-70) |
0.43 |
60
(50-70) |
55
(45-65) |
0.23 |
| PF |
100
(91.66-100) |
100
(91.66-100) |
0.80 |
100
(91.66-100) |
100
(100-100) |
0.06 |
100
(91.66-100) |
100
(91.66-100) |
0.67 |
| RF |
100
(100-100) |
100
(100-100) |
0.54 |
100
(100-100) |
100
(100-100) |
0.24 |
100
(100-100) |
100
(100-100) |
0.73 |
| P |
77.77
(55.55-100) |
77.77
(55.55-100) |
0.45 |
77.77
(55.55-100) |
77.77
(55.55-100) |
0.85 |
77.77
(55.55-100) |
66.66
(55.55-100) |
0.97 |
| SF |
100
(100-100) |
100
(100-100) |
0.07 |
100
(100-100) |
100
(100-100) |
0.82 |
100
(100-100) |
100
(100-100) |
0.71 |
| MH |
68
(60-80) |
68
(56-80) |
0.49 |
68
(56-80) |
72
(60-80) |
0.21 |
68
(56-80) |
68
(52-76) |
0.47 |
| EF |
85
(70-90) |
80
(65-95) |
0.93 |
82.50
(70-90) |
90
(75-100) |
0.13 |
75
(55-90) |
85
(70-90) |
0.09 |
| HD |
95
(80-100) |
95
(75-100) |
0.64 |
95
(77.5-100) |
95
(80-100) |
0.97 |
95
(80-100) |
100
(75-100) |
0.54 |
| CF |
90
(80-100) |
90
(75-100) |
0.99 |
90
(77.5-100) |
95
(80-100) |
0.51 |
90
(75-100) |
85
(80-100) |
0.78 |
| QL |
75
(50-100) |
75
(50-75) |
0.98 |
75
(50-100) |
75
(50-75) |
0.17 |
75
(50-100) |
75
(50-75) |
0.47 |
| HT |
75
(50-75) |
75
(50-75) |
0.95 |
75
(50-75) |
75
(50-75) |
0.27 |
75
(50-75) |
50
(50-75) |
0.82 |
p: Mann-Whitney test, IQR: interquartile range; OIs: opportunistic infections; GHP: General Health Perceptions, PF: Physical Functioning, RF: Role Functioning, P: Pain,
SF: Social Functioning, MH: Mental Health, EF: Energy/Fatigue, HD: Health Distress, CF: Cognitive Functioning, QL: Quality of Life, HT: Health Transition. |
